138 related articles for article (PubMed ID: 36991248)
1. Staphylococcal enterotoxin B as DNA vaccine against breast cancer in a murine model.
Halabian R; Jahangiri A; Sedighian H; Behzadi E; Fooladi AAI
Int Microbiol; 2023 Nov; 26(4):939-949. PubMed ID: 36991248
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy.
Imani Fooladi AA; Halabian R; Mahdavi M; Amin M; Mahmoodzadeh Hosseini H
Tumour Biol; 2016 Jan; 37(1):739-48. PubMed ID: 26245994
[TBL] [Abstract][Full Text] [Related]
3. Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy.
Yousefi F; Siadat SD; Saraji AA; Hesaraki S; Aslani MM; Mousavi SF; Imani Fooladi AA
Tumour Biol; 2016 Apr; 37(4):5305-16. PubMed ID: 26561468
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
[TBL] [Abstract][Full Text] [Related]
5. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
6. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
Guo C; Liu QG; Yang W; Yao YM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
[TBL] [Abstract][Full Text] [Related]
7. Maternal immune activation with staphylococcal enterotoxin A produces unique behavioral changes in C57BL/6 mouse offspring.
Glass R; Norton S; Fox N; Kusnecov AW
Brain Behav Immun; 2019 Jan; 75():12-25. PubMed ID: 29772261
[TBL] [Abstract][Full Text] [Related]
8. Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen.
Yousefi F; Mousavi SF; Siadat SD; Aslani MM; Amani J; Rad HS; Fooladi AA
Technol Cancer Res Treat; 2016 Apr; 15(2):215-26. PubMed ID: 25759426
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects between Staphylococcal enterotoxin type B and Monophosphoryl lipid A against mouse fibrosarcoma.
Imani Fooladi AA; Sattari M; Reza Nourani M
J BUON; 2010; 15(2):340-7. PubMed ID: 20658733
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
Moeini S; Saeidi M; Fotouhi F; Mondanizadeh M; Shirian S; Mohebi A; Gorji A; Ghaemi A
Arch Virol; 2017 Feb; 162(2):333-346. PubMed ID: 27699512
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a recombinant double mutant of staphylococcal enterotoxin B (SEB-H32Q/K173E) with enhanced antitumor activity effects and decreased pyrexia.
Gu L; Yue J; Zheng Y; Zheng X; Wang J; Wang Y; Li J; Jiang Y; Jiang H
PLoS One; 2013; 8(2):e55892. PubMed ID: 23405232
[TBL] [Abstract][Full Text] [Related]
12. Macrophage cell-derived exosomes/staphylococcal enterotoxin B against fibrosarcoma tumor.
Behzadi E; Hosseini HM; Halabian R; Fooladi AAI
Microb Pathog; 2017 Oct; 111():132-138. PubMed ID: 28843722
[TBL] [Abstract][Full Text] [Related]
13. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatments with cyclosporin A and anti-interferon-gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice.
Kuschnaroff LM; Valckx D; Goebels J; Rutgeerts O; Heremans H; Froyent G; Waer M
Scand J Immunol; 1997 Nov; 46(5):459-68. PubMed ID: 9393628
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model.
Mahdavi M; Ebtekar M; Mahboudi F; Khorram Khorshid H; Rahbarizadeh F; Azadmanesh K; Darabi H; Pourasgari F; Hassan ZM
Iran J Immunol; 2009 Dec; 6(4):163-73. PubMed ID: 20054104
[TBL] [Abstract][Full Text] [Related]
16. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.
Matthys P; Mitera T; Heremans H; Van Damme J; Billiau A
Infect Immun; 1995 Apr; 63(4):1158-64. PubMed ID: 7890366
[TBL] [Abstract][Full Text] [Related]
17. T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion.
Florquin S; Amraoui Z; Goldman M
Eur J Immunol; 1995 May; 25(5):1148-53. PubMed ID: 7774618
[TBL] [Abstract][Full Text] [Related]
18. Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade.
Miri SM; Pourhossein B; Hosseini SY; Keshavarz M; Shahmahmoodi S; Zolfaghari MR; Mohebbi SR; Gorji A; Ghaemi A
Virol J; 2022 Jun; 19(1):106. PubMed ID: 35752792
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models.
Nakashima H; Fujisawa T; Husain SR; Puri RK
J Transl Med; 2010 Nov; 8():116. PubMed ID: 21067607
[TBL] [Abstract][Full Text] [Related]
20. The antitumor immunopreventive effects of a DNA vaccine against CYP26a1 on mouse breast carcinoma.
Wang RC; Liu ZK; Chen W; Yang Y; Peng JP
Vaccine; 2011 Nov; 29(48):8915-23. PubMed ID: 21959331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
